Rimonabant for neurocognition in schizophrenia: A 16-week double blind randomized placebo controlled trial
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Objective To examine the effect of rimonabant on neurocognitive impairments in people with schizophrenia. Methods Participants entered a 16-week double-blind, placebo-controlled, randomized clinical trial. A neurocognitive battery was administered at baseline and end of study. Results In comparison to rimonabant (20mg/day), placebo-treated participants exhibited a significant improvement on the Repeatable Battery for the Assessment of Neuropsychological Status total score. In contrast, rimonabant was associated with significant improvement on a probabilistic learning task. There were no other significant treatment effects. Conclusions Rimonabant did not improve global cognitive functioning, but did improve a specific learning deficit based on response to positive feedback.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
By Carrot or by Stick: Cognitive Reinforcement Learning in Parkinsonism
Frank, M. J., Seeberger, L. C., & O'Reilly, R. C. (2004) · Science · doi:10.1126/science.1102941 · Cited by 1,964
Temporal dynamics of brain activation during a working memory task
Cohen, J. D., Perlstein, W. M., Braver, T. S., Nystrom, L. E., Noll, D. C., Jonides, J., & Smith, E. E. (1997) · Nature · doi:10.1038/386604a0 · Cited by 1,876 · cited 1×
“The N-Back task is a sequential letter working memory task (Cohen et al, 1997).”
MethodWaltz, J. A., Frank, M. J., Wiecki, T. V., & Gold, J. M. (2011) · Neuropsychology · doi:10.1037/a0020882 · Cited by 132
Self-citationHorder, J., Cowen, P. J., Di Simplicio, M., Browning, M., & Harmer, C. J. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1517-4 · Cited by 69 · cited 1×
“The examination of rimonabant effects on human cognition has been limited to the study of affective stimuli in normal healthy controls (Horder et al, 2009; Horder et al, 2010).”
Background
Cited by
Miyamoto, S., Miyake, N., Jarskog, L. F., Fleischhacker, W. W., & Lieberman, J. A. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.47 · Cited by 573
Ligresti, A., De Petrocellis, L., & Di Marzo, V. (2016) · Physiological Reviews · doi:10.1152/physrev.00002.2016 · Cited by 469
How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review
Hoch, E., Niemann, D., von Keller, R., Schneider, M., Friemel, C. M., Preuss, U. W., Hasan, A., & Pogarell, O. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-019-00984-4 · Cited by 131
Decision Making and Impulsivity in Young Adult Cannabis Users
O'Donnell, B. F., Skosnik, P. D., Hetrick, W. P., & Fridberg, D. J. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.679904 · Cited by 41
Cannabidiol (CBD) as a novel treatment in the early phases of psychosis
Chesney, E., Oliver, D., & McGuire, P. (2022) · Psychopharmacology · doi:10.1007/s00213-021-05905-9 · Cited by 40
Metadata
- Authors
- Boggs, D. L., Kelly, D. L., McMahon, R. P., Gold, J. M., Gorelick, D. A., Linthicum, J., Conley, R. R., Liu, F., Waltz, J., Huestis, M. A., & Buchanan, R. W.
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2012-02
- Volume
- 134
- Issue
- 2-3
- Pages
- 207-210
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2060584674
- Cited by
- 53
- References
- 4
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rimonabant for neurocognition in schizophrenia: A 16-week double blind randomized placebo controlled trial. https://app.cochat.ai/papers/10.1016/j.schres.2011.11.009
- The paper
- Boggs, D. L., Kelly, D. L., McMahon, R. P., Gold, J. M., Gorelick, D. A., Linthicum, J., Conley, R. R., Liu, F., Waltz, J., Huestis, M. A., & Buchanan, R. W. (2012). Rimonabant for neurocognition in schizophrenia: A 16-week double blind randomized placebo controlled trial. Schizophrenia Research. https://doi.org/10.1016/j.schres.2011.11.009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.